Citi Knock-Out PGR/ DE000KJ37H07 /
2024-04-09 9:31:43 AM | Chg.-0.070 | Bid2:56:46 PM | Ask- | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
5.590EUR | -1.24% | - Bid Size: - |
- Ask Size: - |
Progressive Corporat... | 150.6077 - | 2078-12-31 | Call |
GlobeNewswire
05-01
Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 A...
GlobeNewswire
05-01
Capital Bank Welcomes Todd Warren as Market Executive for the Greater Chesapeake and Baltimore Regio...
GlobeNewswire
05-01
Wine, Beer, and Spirits Continues its Evolution: National Accolades, Industry Memberships and Leader...
GlobeNewswire
05-01
Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 ...
GlobeNewswire
05-01
Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geog...
GlobeNewswire
05-01
Atsena Therapeutics Announces Positive Clinical Data from the First Cohort of Phase I/II Trial Evalu...
GlobeNewswire
05-01
TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
05-01
Apellis Announces 11 Oral Presentations at the Association for Research in Vision and Ophthalmology ...
GlobeNewswire
05-01
Navigator Gas Releases ESG 2023 Report: Demonstrating Commitment to Sustainability and Social Respon...
GlobeNewswire
04-25
Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Re...
GlobeNewswire
04-24
Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society...
GlobeNewswire
04-22
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Snap One Ho...
GlobeNewswire
04-22
Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients i...
GlobeNewswire
04-19
Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Scleros...
GlobeNewswire
04-18
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with B...
GlobeNewswire
04-18
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple ...